Related Experiment Videos
Cochlear implantation in child
1Hardstrasse 60, Basel, Switzerland.
Insights
Cochlear implants show significant hearing improvements in congenitally deaf children. Post-meningitic children with cochlear implants performed similarly to non-meningitic peers, supporting their candidacy.
Area of Science:
- Audiology
- Biomedical Engineering
- Pediatric Medicine
Background:
- The Nucleus 22-channel cochlear implant system is FDA-approved for pediatric use.
- Patient selection for pediatric cochlear implantation remains a critical consideration.
- Specific pediatric populations, such as congenitally deaf and post-meningitic children, warrant careful evaluation.
Purpose of the Study:
- To present a statistical method for reporting cochlear implant outcomes in pediatric patients.
- To evaluate the performance of two distinct pediatric cochlear implant candidate groups: congenitally deaf and post-meningitic children.
- To address concerns regarding the suitability of these groups as cochlear implant candidates.
Main Methods:
- Utilized a statistical approach aggregating single-subject, repeated measures data.
- Applied the method to analyze performance data from congenitally deaf children.
- Applied the method to analyze performance data from profoundly deaf children with meningitis.
Main Results:
- Congenitally deaf children demonstrated statistically significant improvements in performance after cochlear implantation.
- Post-meningitic children showed no significant difference in overall performance compared to non-meningitic children.
- The findings suggest these populations can achieve successful outcomes.
Conclusions:
- The statistical method provides a robust way to assess cochlear implant outcomes in pediatric populations.
- Congenitally deaf children benefit significantly from cochlear implantation.
- Cochlear implantation is appropriate for post-meningitic children, with performance comparable to other groups.
Abstract:
Implants in children of the Nucleus 22-channel system have recently been approved in the United States by the Food and Drug Administration (FDA). Several questions still remains, however, concerning patient selection. This paper presents a statistical method of reporting results and its application to two populations of cochlear implant candidates: congenitally deaf children, and profoundly deaf children with meningitis as the cause of their deafness. It has been suggested that as these two groups may have significantly lower performance than other populations, it may not be appropriate to select them as implant candidates. The statistical method used aggregated single-subject, repeated measures data to reach conclusions on performance. Findings for congenitally deaf subjects evidenced significant improvements over preoperative performance. Results for post-meningitic children showed no significant difference in overall performance compared to non-meningitic children.